Location History:
- Adachi-ku, JP (2012)
- Tokyo, JP (2021)
Company Filing History:
Years Active: 2012-2021
Title: Innovations of Tetsuro Matano in Vaccine Development
Introduction
Tetsuro Matano is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of vaccine development. With a total of two patents to his name, Matano has focused on creating innovative solutions to combat infectious diseases.
Latest Patents
One of Matano's latest patents is for an infectious disease vaccine using a non-infectious paramyxovirus particle. This invention involves the production of a non-infectious particle that comprises a pathogen antigen protein expressed on the surface of a virus particle missing at least one species of paramyxovirus envelope protein. This particle has been shown to contain a larger amount of antigen protein compared to infectious particles, enabling it to elicit a host immune response with exceptional efficiency. The non-infectious particle is particularly useful as a vaccine against pathogenic viruses.
Another notable patent by Matano is related to AIDS virus vaccines using a Sendai virus vector. This invention provides a vaccine that contains a Sendai virus vector encoding a virus protein of an immunodeficiency virus. By intranasally administering this vaccine to macaque monkeys, Matano and his team successfully induced protective immunity against the immunodeficiency virus. The results showed that the vaccine led to significant expression of antigen protein in the intranasal mucous membrane and local lymph nodes, inducing a strong antigen-specific cellular immune response without any pathological symptoms. Following vaccination, exposure to simian immunodeficiency virus resulted in a significant decrease in the amount of virus in plasma compared to control animals, highlighting the potential of this vaccine as an effective AIDS treatment.
Career Highlights
Throughout his career, Tetsuro Matano has worked with esteemed organizations, including the National Institute of Infectious Disease and Id Pharma Co., Ltd. His work has been instrumental in advancing vaccine technology and improving public health outcomes.
Collaborations
Matano has collaborated with notable colleagues such as Makoto Inoue and Hiroto Hara, contributing to the success of his innovative projects.
Conclusion
Tetsuro Matano's work in vaccine development showcases his dedication to addressing critical health challenges through innovative solutions. His patents reflect a commitment to advancing medical science and improving the efficacy of vaccines against infectious diseases.